Show simple item record

EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY

dc.contributor.authorTakeno, Mitsuhiro
dc.contributor.authorParis, Maria
dc.contributor.authorChen, Mindy
dc.contributor.authorYazici, Yusuf
dc.contributor.authorHatemi, Gulen
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorSaadoun, David
dc.contributor.authorKim, Doyoung
dc.contributor.authorMahr, Alfred
dc.contributor.authorCheng, Sue
dc.contributor.authorMccue, Shannon
dc.date.accessioned2021-03-03T12:11:53Z
dc.date.available2021-03-03T12:11:53Z
dc.identifier.citationHatemi G., Mahr A., Takeno M., Kim D., Saadoun D., Direskeneli H., Cheng S., Mccue S., Paris M., Chen M., et al., "EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY", Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.148-149
dc.identifier.othervv_1032021
dc.identifier.otherav_2c7f82e0-2dd0-4622-b201-d17c5d29c05f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/34603
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2019-eular.1651
dc.language.isoeng
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectİmmünoloji ve Romatoloji
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.titleEFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY
dc.typeBildiri
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume78
dc.contributor.firstauthorID156276


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record